Healthcare AI Acquisition Corp.
HAIAF$71M
Micro CapNASDAQBlank Checks🇺🇸North AmericaALBANY
Drugs in Pipeline
5
Phase 3 Programs
4
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
HAIAF News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Gadodiamide Injection
Renal Artery Stenosis
Sodium Alginate Double Action Chewable Tablets
Gastroesophageal Reflux Disease
Ibuprofen 300 mg Oral Tablet
Pain
Compound Sodium Alginate Oral Suspension sachet
Gastro-esophageal Reflux Disease (GERD)
[18F] Flutemetamol
Mild Cognitive Impairment
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Gadodiamide Injection | Phase 3 | Renal Artery Stenosis | - | - |
Sodium Alginate Double Action Chewable Tablets | Phase 3 | Gastroesophageal Reflux Disease | - | - |
Ibuprofen 300 mg Oral Tablet | Phase 3 | Pain | - | - |
Compound Sodium Alginate Oral Suspension sachet | Phase 3 | Gastro-esophageal Reflux Disease (GERD) | - | - |
[18F] Flutemetamol | Phase 2 | Mild Cognitive Impairment | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply